Skip to content


Malaria Journal

What do you think about BMC? Take part in

Featured article

Long-term culture of P. vivax is possible in the RBCs of Saimiri boliviensis.

2.5 billion people live at risk of Plasmodium vivax malaria. Inability to grow this parasite in the laboratory limits vivax malaria drug and vaccine development. Saimiri boliviensis is recognized as receptive to P. vivax infection. Using S. boliviensis blood, we have succeeded in long-term culture of P. vivax collected in rural Madagascar. This system avoids whole animal infections and introduces new capacity for P. vivax laboratory studies.


View all articles
View all articles

Aims and Scope

Malaria Journal is aimed at the scientific community interested in malaria in its broadest sense. It is the only journal that publishes exclusively articles on malaria and, as such, it aims to bring together knowledge from the different specialties involved in this very broad discipline, from the bench to the bedside and to the field. Malaria Journal offers a fast publication schedule while maintaining rigorous peer-review; this is achieved by managing the whole of the publication process electronically, from submission to peer-review.

Editor-in-Chief - Marcel Hommel, University of Liverpool, UK

Latest Tweets

Latest collections

ACT now: anti-malarial market complexity one decade after the introduction of artemisinin combination therapy – evidence from sub-Saharan Africa and the Greater Mekong Sub-region

ACTwatch report on their 10-year monitoring of ACT usage in sub-Saharan Africa and in the Greater Mekong sub- region, make recommendations and share their data with the malaria community. They have spoken to BugBitten about their work and their motivation for making their datasets publicly available.

Ivermectin to reduce malaria transmission

Ivermectin has been used to treat some NTDs for years, but its potential use to block malaria transmission is not well known. Carlos Chaccour and colleagues review the role the ivermectin can play in reducing malaria. Carlos Chaccour and Regina Rabinovich also discuss the series and ivermectin in their interview with BugBitten blog.